Replies to post #157 on Tyme Technologies Inc. (TYME)

[Inoviorulez]

Correct, TYME has already shown good results in 2 different types of cancer. Lots of catalysts coming up, about 5 in 2nd half of 2019.

[BottomBounce]

$TYME TYME Analyst Ratings CONSENSUS Strong Buy
Based on 1 analysts offering recommendations for tyme in the last 3 months.
Analyst Target Price $9.5. Based on analysts offering 12 month price targets for TYME in the last 3 months. The average price target is $9.5 with a high estimate of $9.5 and a low estimate of $9.5. https://new.nasdaq.com/market-activity/stocks/tyme/analyst-research